Lonza Group AG
LONN
株式のランク
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
株価
$763.31
時価総額
$53.31B
変化（1日）
0.87%
変化（1年）
8.49%
国
CH
取引 Lonza Group AG (LONN)
カテゴリー
Healthcare
Lonza Group AG（LONN）の営業利益率
2026 時点の営業利益率 TTM: 0.00%
Lonza Group AG の最新の財務報告と株価によると、現在の営業利益率（TTM）は 0.00% です。2026 年末時点では 0.00% でした。
Lonza Group AG の営業利益率の履歴（2004 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2025 | 21.16% | 44.34% |
| 2024 | 14.66% | 11.91% |
| 2023 | 13.10% | -47.09% |
| 2022 | 24.76% | 57.41% |
| 2021 | 15.73% | -24.34% |
| 2020 | 20.79% | -4.72% |
| 2019 | 21.82% | 19.76% |
| 2018 | 18.22% | 0.94% |
| 2017 | 18.05% | 20.90% |
| 2016 | 14.93% | 14.06% |
| 2015 | 13.09% | 6.86% |
| 2014 | 12.25% | 7.36% |
| 2013 | 11.41% | 33.61% |
| 2012 | 8.54% | -11.96% |
| 2011 | 9.70% | -30.52% |
| 2010 | 13.96% | 57.21% |
| 2009 | 8.88% | -40.88% |
| 2008 | 15.02% | 5.63% |
| 2007 | 14.22% | 7.97% |
| 2006 | 13.17% | 11.80% |
| 2005 | 11.78% | 21.82% |
| 2004 | 9.67% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 28.81% | - |
NL
|
|
| 31.23% | - |
BE
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。